2023-08-14 02:40:36
By the end of the year, it is planned to produce more than 1.9 million doses of the new drug.
Federal Research Center for Research and Development of Immunobiological Preparations named after V.I. M.P. Chumakov Russian Academy of Sciences (Polio Institute) plans to produce more than 1.9 million doses of a new polio drug by the end of 2024. This was reported on August 14 in the press service of the Russian Academy of Sciences.
– The new polio vaccine “Poliovaxin” will replace the foreign vaccine that was previously used in the Russian National Immunization Schedule. Our drug has been developed since 2017, within a few years it has successfully passed all the necessary clinical trials and received a registration certificate from the Ministry of Health, – the press service of the Director General of the Center, Academician of the Russian Academy of Sciences Aidar Ishmukhametov quotes.
Previously, a polio drug was produced in the country, it used a live virus. The new vaccine “Poliovaxin” was also created from Sabin strains, but the virus in it is inactivated, i.e. dead, greatly increasing her security.
1692097078
#Russia #develops #inactivated #polio #vaccine